Rapid conversion of naive to effector T cell function counteracts diminished primary human newborn T cell responses

Clinical and Experimental Immunology

Volumn 116, Issue 3, 1999, Pages 527-533

  Early, E ^a   Reen, D J ^a  

^a OUR LADY S CHILDREN S HOSPITAL   (Ireland)

Author keywords

CD4+CD45RA+; CD4+CD45RO+; In vitro conversion; Newborn

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVITY; CELL STIMULATION; CYTOKINE PRODUCTION; HELPER CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENCE; IMMUNOCOMPETENT CELL; IN VITRO STUDY; INTERFERON PRODUCTION; LYMPHOCYTE FUNCTION; LYMPHOCYTE TRANSFORMATION; NEWBORN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; ANTIGENS, CD45; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; FETAL BLOOD; HUMANS; INFANT, NEWBORN; KINETICS; PHENOTYPE; TH1 CELLS;

EID: 0032997984     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00920.x     Document Type: Article

References (41)

1. Akbar AN, Terry L, Timms A, Beverley PCL, Janossy G. Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells. J Immunol 1988; 140:2171-6.
2. Sanders ME, Makogoba MW, Shaw S. Human naive and memory T cells: reinterpretation of helper-inducer and suppressor-inducer subsets. Immunol Today 1988; 9:195-9.
3. Plebanski M, Saunders M, Burtles SS, Crowe S, Hooper DC. Primary and secondary human in vitro T-cell responses to soluble antigens are mediated by subsets bearing different CD45 isoforms. Immunol 1992; 75:86-91.
4. De Paoli P, Battistin S, Santini G. Age related changes in human lymphocyte subsets: progressive reduction of the CD4/CD45R (suppressor inducer) population. Clin Immunol Immunopathol 1988; 48:290-6.
5. Hannet I, Erkeller-Yuksel F, Lydyard P, Deneys V, De Bruyene M. Development and maturational changes in human blood lymphocyte subpopulations. Immunol Today 1992; 13:215-8.
6. Clement LT, Yamashita N, Martin AM. The functionally distinct subpopulations of human helper/inducer T lymphocytes defined by anti-CD45R antibodies derive sequentially from a differentiation pathway that is regulated by activation-dependent post-thymic differentiation. J Immunol 1988; 141:1464-70.
7. Serra HM, Krowka JF, Ledbetter JA, Pilarski LM. Loss of CD45R (Lp220) represents a post-thymic T cell differentiation event. J Immunol 1988; 140:1441-5.
8. Kristensson K, Dohlsten M, Fischer H, Ericsson PO, Hedlund G, Sjogren HO, Carlsson R. Phenotypical and functional differentiation of CD4+/CD45RA+ human T cells following polyclonal activation. Scand J Immunol 1990; 32:243-53.
9. Rothstein DM, Sohen S, Daley JF, Schlossman SF, Morimoto C. CD4+CD45RA+ and CD4+CD45RA T cell subsets in man maintain distinct function and CD45RA expression persists on a subpopulation of CD45RA+ cells after activation with ConA. Cell Immunol 1990; 129:449-67.
10. Wallace L, Beverley PCL. Phenotypic changes associated with activation of CD45RA+ and CD45RO+ T cells. Immunol 1990; 69:460-7.
11. Ferrer JM, Plaza A, Kreisler M, Diaz-Espada F. Differential interleukin secretion by in vitro activated human CD45RA and CD45RO CD4+ T tell subsets. Cell Immunol 1992; 141:10-20.
12. Brod SA, Rudd CE, Purvee M, Hafler DA. Lymphokine regulation of CD45R expression on human T cell clones. J Exp Med 1989; 170:214-51.
13. Rothstein DM, Yamada A, Schlossman SF, Morimoto C. Cyclic regulation of CD45 isoform expression in a long-term human CD4+CD45RA+ T cell line. J Immunol 1991; 146:1175-82.
14. Bell EB, Sparshott SM. Interconversion of CD45R subsets of CD4 T cells in vivo. Nature 1990; 348:163-6.
15. Merkenschlager M. Confusion over CD45 iosform. Nature 1991; 352:28.
16. Clement LT. Isoforms of the CD45 common leucocyte antigen family: markers for human T-cell differentiation. J Clin Immunol 1992; 12:1-10.
17. LaGamma EF, Drusin LM, Mackles AW, Machalek S, Auld PAM. Neonatal infections. An important determinant of late NICN mortality in infants less than 1,000 g at birth. Am J Dis Child 1983; 137:831-8.
18. Baley JE, Goldfarb J. Neonatal infections. In: Klaus MH, Fanaroff AA, eds. Care of the high-risk neonate, 4 edn. Philadelphia: W.B. Saunders, Co., 1993:323-44.
19. Vesikari T, Janas M, Gronroos P et al. Neonatal septicemia. Arch Dis Child 1985; 60:542-6.
20. Broxmeyer HE, Douglas GW, Hangoc G et al. Human umbilical cord blood as a potential source of transplantable haematopoietic stem/ progenitor cells. Proc Natl Acad Sci USA 1989; 86:328-32.
21. Gluckman E, Broxmeyer HE, Aurbrach A et al Haematopoietic reconstitution in a patient with Fanconi' 's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989; 321:1174-8.
22. Van Bekkum DW. In: Gale RP, Fox CE, eds. The biology of bone marrow transplantation. San Diego: Academic Press, 1980:175.
23. Andersson U. Bird AG, Britton S, Palacios R. Humoral and cellular immunity in human studies at the cell level from birth to two years of age. Immunol Rev 1991; 57:37.
24. Splawaski JB, Jelinek DF, Lipsky PE. Delineation of the functional capacity of human neonatal lymphocytes. J Clin Invest 1991; 87:545-50.
25. Ueno Y, Ichihara M, Hasuig M, Maruyama H, Miyawaki T, Taniguchi N, Komiyama A. T-cell dependent production of JgG by human cord blood B cells in reconstituted SCID mouse. Scand J Immunol 1992; 35:415-22.
26. Bertotto A, Gerli R, Lanfrancone L, Crupi S, Arcangeli C, Cernetti C, Spinozzi F, Rambotti P. Activation of cord T lymphocytes. II. Cellular and molecular analysis of the defective response induced by anti-CD3 monoclonal antibody. Cell Immunol 1990; 127:247-53.
27. Miyawaki T, Seki H, Taga K, Sato H, Taniguchi N. Dissociated production of interleukin-2 and immune (γ) interferon by phytohaemagglutinin stimulated lymphocytes in healthy infants. Clin Exp Immunol 1985; 59:505-10.
28. Wakasugi N, Virelizier J, Arenzana-Seisdedos F, Rothhut B, Heurta JM, Russo-Marie F, Fiers WE. Defective IFN-γ production in the human neonate. II. Role of increased sensitivity to the suppressive effects of prostaglandin E. J Immunol 1985; 134:172-8.
29. Lewis DB, Yu CC, Meyer J, English BK, Kahn SJ, Wilson CB. Cellular and molecular mechanism for reduced interleukin 4 and interferon-γ production hy neonatal T cells. J Clin Invest 1991; 87:194-8.
30. Wilson CB. The ontogeny of T lymphocyte maturation and function. J Pediatr 1991; 118:S4.
31. Risdon G, Gaddy J, Stehman FB, Broxmeyer HE. Proliferation and cytotoxic responses of human cord blood T lymphocytes following allogeneic stimulation. Cell Immunol 1994; 154:14-24.
32. Risdon G, Gaddy J, Broxmeyer HE. Allogeneic responses of human umbilical cord blood. Blood Cells 1994; 20:566-72.
33. Gerli R, Bertotto A, Crupi S et al. Activation of cord T lymphocytes. I. Evidence for a defective T cell mitogenesis induced through the CD2 molecule. J Immunol 1989; 142:2583-9.
34. Hassan J, Reen DJ. Neonatal CD4+CD45RA+ T cells. Precursors of adult CD4+CD45RA+ T cells? Res Immunol 1993; 144:87-92.
35. Early EM, Reen DJ. Antigen-independent responsiveness to interleukin-4 demonstrates differential regulation of newborn human T cells. Eur J Immunol 1996; 26:2885-9.
36. Kaplan ME, Clark C. An improved resetting assay for detection of human T lymphocytes. J Immunol Methods 1974; 5:131-9.
37. Clement LT, Vink PE, Bradley GE. Novel immunoregulatory functions of phenotypically distinct subpopulations of CD4+ cells in the human neonate. J Immunol 1990; 145:102-8.
38. Hodge S, Hodge G, Flowe R, Han P. Surface activation markers of T lymphocytes: role in the detection ot infection in neonates. Clin Exp Immunol 1998; 113:33-38.
39. Tezuka T, Sugita K, Mizobe N et al. Transient increase in CD45RO expression on T lymphocytes in infected newborns. Pediatr Res 1998; 43:282-90.
40. Huet S, Wakasugi H, Sterkers G, Gilmours J, Turz T, Boumseil L, Bernard A. T cell activation via CD2 (T, gp50): the role of accessory cells in activating resting T cells via CD2. J Immunol 1980; 137:1415-20.
41. Brottier P, Bounsell L, Gelin C, Bernard A. T cell activation via CD2 (T, gp50) molecules: accessory cells are required to trigger T cell activation via CD2 D66 plus CD2-9.6/T11 epitopes. J Immunol 1985; 135:1624-31.